Synergistic Dual-Peptide Regenerative Stack
Wolverine Blend — BPC-157 + TB-500 Combination
The Wolverine Blend is a pre-combined formulation of two of the most extensively researched recovery peptides available: BPC-157 and TB-500. Named for the comic archetype of rapid, near-instantaneous tissue regeneration, this blend is designed to leverage the complementary and potentially synergistic mechanisms of both compounds in a single reconstitutable vial.
BPC-157 contributes its well-characterized angiogenic and cytoprotective activity — particularly its upregulation of VEGFR2 and modulation of the nitric oxide system — while TB-500 provides systemic actin-regulatory and cell-migratory support through its WH2 domain binding activity. Together, the two peptides address tissue repair from both a local vascular and a systemic cellular migration standpoint.
The Wolverine Blend contains a fixed-ratio combination of BPC-157 (Body Protection Compound 157, a 15-amino-acid pentadecapeptide, MW 1,419.56 Da) and TB-500 (the Ac-LKKTETQ heptapeptide fragment of thymosin beta-4, MW 887.0 Da). Both components are supplied as co-lyophilized powder in a single vial, maintaining ≥99% purity for each constituent as verified by independent third-party certificate of analysis.
The rationale for co-formulation is rooted in the complementary nature of the two peptides' mechanisms: BPC-157 primarily acts at the local tissue level through angiogenic and growth factor signaling, while TB-500 exerts systemic effects on cell migration and cytoskeletal dynamics, potentially enabling a more comprehensive regenerative response than either compound alone.
The Wolverine Blend operates through the combined mechanisms of its two constituent peptides. BPC-157 activates the VEGFR2 pathway to stimulate angiogenesis and upregulates Egr-1 to drive expression of PDGF, FGF, and other repair-associated growth factors. Simultaneously, it modulates the nitric oxide system to provide cytoprotective and vascular tone-regulating effects.
TB-500 complements this by binding monomeric G-actin via its WH2 domain, enabling the directed migration of fibroblasts, endothelial cells, and keratinocytes into the wound bed. It also activates the Akt/PI3K survival pathway and downregulates pro-inflammatory cytokines IL-1β and TNF-α, reducing the inflammatory burden that can impede healing.
The theoretical synergy between these mechanisms — local angiogenesis plus systemic cell migration — has made the BPC-157/TB-500 combination one of the most discussed dual-peptide stacks in preclinical recovery research.
The Wolverine Blend combines two of the most studied recovery peptides — BPC-157 and TB-500 — into a single vial. The name is a nod to the comic book character famous for near-instant healing, and the idea behind the blend is that the two compounds target tissue repair from different angles simultaneously.
BPC-157 works locally — it signals the body to grow new blood vessels at the site of damage, which is the critical first step in any healing process. TB-500 works more systemically — it helps repair cells throughout the body navigate toward the injury. Together, researchers hypothesize that you get both the 'build the roads' signal (BPC-157) and the 'send the workers' signal (TB-500) at the same time.
Most recovery peptides address one part of the healing cascade. The appeal of a dual-compound blend is that it theoretically covers more ground in a single protocol. This is why the BPC-157/TB-500 combination is one of the most discussed stacks in preclinical recovery research — the mechanisms genuinely complement each other rather than overlap.
The Wolverine Blend is a convenient co-formulation of two individually well-studied compounds. The synergy hypothesis is mechanistically sound, though direct studies on the combination specifically are limited. Both components are research-only compounds; no human clinical data exists for this specific blend.
BPC-157 component upregulates VEGFR2, driving new blood vessel formation and improving perfusion at sites of tissue injury.
TB-500 component binds G-actin via WH2 domain, enabling directed migration of repair cells into the wound bed.
TB-500 activates the Akt survival pathway, protecting cells from ischemic and inflammatory damage during the repair process.
BPC-157 modulates nitric oxide while TB-500 suppresses IL-1β and TNF-α, collectively reducing inflammatory impedance to healing.
Recovery Research
≥99% purity · Third-party tested
Use code Health for 15% off
Fast FedEx shipping · 60-day guarantee
| Blend Components | BPC-157 (pentadecapeptide) + TB-500 (heptapeptide) |
| BPC-157 MW | 1,419.56 Da |
| TB-500 MW | 887.0 Da |
| Form | Co-lyophilized powder blend |
| Purity (each component) | ≥99% (third-party tested) |
| Reconstitution | Bacteriostatic water (BAC Water) |
View full legal status guide →
Purgo Labs offers Wolverine Blend with ≥99% purity, third-party certificates of analysis, and fast FedEx shipping. This is an affiliate link — we may earn a commission at no cost to you.
Purchase Wolverine Blend at Purgo LabsMedical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.
